BD Stuck With $114M Antitrust Verdict After New Trial Denied
A Texas federal judge on Tuesday rejected Becton Dickinson & Co.'s bid to ax a $113.5 million damages verdict in favor of Retractable Technologies Inc. and send the syringe market monopolization...To view the full article, register now.
Already a subscriber? Click here to view full article